GlassScriptPhysician profile
Antonio L Carr
NPI 1801818349
$500.05
in general payments reported to CMS, 2019-2025
11 companies · $63.61 in 2025
The $63.61 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $257 · 2024: $179 · 2025: $63.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $83.26 | 2024-2025 | Cobenfy |
| Alkermes, INC. | $67.86 | 2023 | Aristada, Lybalvi, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $67.40 | 2023-2024 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $65.94 | 2023-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Indivior INC. | $60.21 | 2023 | Perseris |
| Abbvie INC. | $48.72 | 2023-2024 | Vraylar |
| Janssen Pharmaceuticals, INC | $35.36 | 2024 | Invega |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.22 | 2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $19.05 | 2024 | Fanapt |
| Baxter Healthcare | $18.78 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $13.25 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.